Study of Myelin-producing Cells a Step Forward for MS, Other Neurological Disorders
A study found that the cells responsible for the production of myelin selectively introduce a myelin-insulating layer in a particular set…
Articles by Patricia Inacio, PhD
Stress Urinary Incontinence Can Often Affect Mothers with Relapsing MS
Stress urinary incontinence affects predominantly young adult mothers with relapsing-remitting multiple sclerosis (RRMS), particularly those with pelvic organ prolapse, according…
Tysabri May Be More Effective Than Gilenya at Reducing Disease Activity in MS Patients, Study Says
An indirect comparison of results from randomized clinical trials in relapsing-remitting multiple sclerosis (RRMS) patients suggests that Tysabri (natalizumab) is…
#ECTRIMS2016 – Gilenya Study Shows Long-term Benefits for MS Patients
Novartis recently announced positive results from the ACROSS study, which is assessing the clinical effect of Gilenya (fingolimod) in 10-year…
#ECTRIMS2016 – MS Patients Achieve Sustained Improvements in Mobility with Ampyra
A recent study showed that the clinical benefits offered by Ampyra (fampridine) in improving mobility among multiple sclerosis (MS) patients…
#ECTRIMS2016 – Lemtrada and Tysabri Seen as Most Effective Therapies for MS in 5-Year Study
A five-year study comparing the efficacy of different treatments for relapsing-remitting multiple sclerosis (RRMS) found that, in general, Lemtrada (alemtuzumab) and Tysabri…
#ECTRIMS2016 – Vitamin D Deficiency Linked to Higher Risk of MS for Women in Finland
In a large nationwide study in Finland, researchers found evidence supporting the link between vitamin D deficiency and an increased…
#ECTRIMS2016 – MS Patients May Be at Lower Risk for Other Illnesses, Danish Study Suggests
Preliminary results of a study in Danish patients with multiple sclerosis (MS) suggest that inverse comorbidity may exist in the…
#ECTRIMS2016 – Poor Medication Adherence in Pediatric MS Patients Linked to Fatigue, Lack of Routine
Children with multiple sclerosis (MS) in North America identified a number of challenges in adhering to disease-modifying therapies — a potential first step…
#ECTRIMS2016 – Vitamin D3 Oil Supplements May Benefit MS Patients in Early Disease Stages
Patients with relapsing-remitting multiple sclerosis (RRMS) might benefit from cholecalciferol (vitamin D3) oil as an add-on therapy in the early phases of…
#ECTRIMS2016 – Modeling Approach Able to Identify Likely Disease Trajectory in Progressive MS Patients
Long-term observations together with mathematical modeling present a way of predicting the likely disability trajectory of multiple sclerosis (MS) patients. The approach was outlined in a presentation, titled…
#ECTRIMS2016 – Stem Cell Transplantation Shows High Efficiency
A high fraction of patients with multiple sclerosis (MS) who underwent a transplant with their own bone marrow stem cells…
#ECTRIMS2016 – Protein Seen as New Target in Preventing Brain Inflammation in MS
Researchers found that blocking a protein, known as integrin alpha 8, may work to prevent inflammation in the central nervous system of patients…
#ECTRIMS2016 – Investigational Leustatin Tablets Offer Clinical Benefits to Different MS Patients
Leustatin (cladribine) tablets, an investigational drug, were shown to be effective at reducing annual relapse rates, not only in MS patients, but…
#ECTRIMS2016 – Benefits of Gilenya in MS Also Appear Linked to Its Effects on B-Cells
Scientists recently reported additional mechanisms of action that may underlie Gilenya (fingolimod) beneficial effects in relapsing-remitting multiple sclerosis (RRMS). The results…
#ECTRIMS2016 – Cognitive Problems in MS Patients Linked to Lower Income, Study Reports
In a recent talk, titled “Income and cognitive impairment among multiple sclerosis patients,” scientists investigated how cognitive impairment impacts the life…
Researchers Reveal Mechanism of Action for Tecfidera, an MS Therapy
Researchers found the molecular target of the multiple sclerosis (MS)-approved drug Tecfidera, (dimethyl fumarate or DMF), unveiling the…
Cognitive Toll of MS Can Include Ability to Handle Personal Finances, Study Finds
People with multiple sclerosis, especially those with cognitive disabilities, have more problems managing their personal finances — paying bills on…
Steroid Use Lowers Oxidative Stress in Cerebrospinal Fluid of Progressive MS Patients in Pilot Study
A pilot study in patients with progressive multiple sclerosis (MS) found a steroid treatment of benefit by decreasing oxidative stress in the cerebrospinal fluid. The study,…
Cognitive Skills Maintained in RRMS Patients Treated with Gilenya or Tysabri in Yearlong Study
Disease-modifying therapies, a group of treatments for people with relapsing-remitting multiple sclerosis (RRMS), work to stabilize patients’ cognitive functions just as they do their…
Gut Microbiota Seen to Differ in People with Relapsing MS, Especially Those with Active Disease
Fecal samples from a group of people with relapsing-remitting multiple sclerosis (RRMS) showed evidence of a different gut microbiota than…
Zinbryta (Daclizumab) Approved in Europe to Treat Relapsing MS
Biogen and AbbVie announced that the drug Zinbryta (daclizumab) has received marketing authorization by the European Commission, and is an…
New MRI Method Has Potential to Map MS Progression and Guide Treatment
Researchers working with magnetic resonance imaging (MRI) are often faced with a problem: an average MRI brain scan produces a considerable amount…
Vitamin D Levels Seen to Predict Relapse Rates Only in Younger MS Patients
A retrospective study of vitamin D status and disability progression in multiple sclerosis patients — using real-life, clinical data from a large and varied…
‘Master Switch’ for Autoimmune Diseases Like MS Potentially Seen in DNA of Immune Cells
Regions of DNA called super-enhancers regulate immune cell activity, including the body’s response to threats like inflammation or pathogens, and now scientists…
First MS Patients in CHANGE-MS Trial Receive Novel Treatment
GeNeuro, a biopharmaceutical company that focuses on novel treatments for autoimmune diseases such as multiple sclerosis (MS), announced that the first…
Familial MS Linked to Single Genetic Mutation
A single genetic mutation in a gene called Nr1h3, can cause familial multiple sclerosis (MS), reported scientists from the…
Sexual Function for MS, Other Patients with Neurological Disorders Can Improve with Help
Sexual dysfunction is common for patients affected by neurological disorders, but it does not have to signal the end of…
Scientists Gather to Discuss Novel Connections Between Gut Microbiome and Brain Disorders
Increasing evidence suggests that our gut microbiome is able to regulate brain processes and trigger neurological disorders, such as multiple…
#CMSC16 – RRMS Patients’ Five-Year Clinical Outcome Improved Through Combined Immunosuppresive Therapy, Cell Transplantation
Results from a Phase 2 clinical trial showed that five-year clinical outcomes of patients with highly active relapsing-remitting multiple sclerosis (RRMS)…